USPTO trademark

CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY

Under examinationUSPTOWord markClass 5Class 42Class 44

"CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY" is a word mark owned by Seqirus Inc., filed at the USPTO on April 21, 2026. It is under examination and covers classes 5, 42 and 44.

View Seqirus Inc. portfolioGet this data via the API
Official USPTO record
CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY trademark as filed
As filed with the USPTO
Status
Under examination
Since September 1, 2026
Filed
April 21, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99777553
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Seqirus Inc.

Holly Springs, United States

231 trademarks in the portfolioView company

Representative

Nancy Sabarra

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY is filed for, grouped by Nice class.

  • Vaccines; vaccines for human use; flu vaccines

  • Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development

  • Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY

Who owns the trademark "CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY"?

The USPTO trademark "CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY" (application 99777553) is owned by Seqirus Inc.

What is the status of "CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019dbd19-0d3f-7197-937f-ba03ec54059a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019dbd19-0d3f-7197-937f-ba03ec54059a",
  "object": "trademark",
  "mark_text": "CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99777553",
  "filing_date": "2026-04-21",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "Seqirus Inc.",
      "entity_id": "ent_019eb7d7-073e-746b-967e-2a965cfa764c"
    }
  ]
}